Bioactive anti-obesity food components

International Journal for Vitamin and Nutrition Research

Volumn 82, Issue 3, 2012, Pages 148-156

  Martínez Augustin, Olga ^a,b   Aguilera, Concepción María ^a   Gil Campos, Mercedes ^c   de Medina, Fermín Sánchez ^a,b   Gil, Angel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Food components; Nutritional supplements; Obesity

Indexed keywords

CARNITINE; CONJUGATED LINOLEIC ACID; DIACYLGLYCEROL; ESTRONE; GAMMA LINOLENIC ACID; LEPTIN; NICOTINAMIDE; OMEGA 3 FATTY ACID; PYRUVIC ACID; RESVERATROL; SOYBEAN OIL; SOYBEAN PROTEIN; TRIACYLGLYCEROL; ANTIOBESITY AGENT; PHENOL DERIVATIVE;

ADIPOCYTE; ADIPOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; APPETITE; ARTICLE; CELL DIFFERENTIATION; DIETARY FIBER; DYSLIPIDEMIA; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FATTY LIVER; FOOD COMPOSITION; FOOD INTAKE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; METABOLIC RATE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; SATIETY; SUDDEN DEATH; WAIST CIRCUMFERENCE; WEIGHT CONTROL; WEIGHT REDUCTION; CHEMISTRY; DIET SUPPLEMENTATION; FOOD; FOOD ANALYSIS; REVIEW; SOYBEAN;

ANTI-OBESITY AGENTS; DIETARY FIBER; DIETARY SUPPLEMENTS; DIGLYCERIDES; FATTY ACIDS, OMEGA-3; FOOD; FOOD ANALYSIS; GAMMA-LINOLENIC ACID; HUMANS; LINOLEIC ACIDS, CONJUGATED; OBESITY; PHENOLS; SOYBEANS;

EID: 84874136479     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000105     Document Type: Article

References (70)

1. World Health Organization. (2004) Global strategy on diet, physical activity and health, 1-18.
2. Reaven, G.M. (2005) The insulin resistance syndrome: definition and dietary approaches to treatment. Annual Review of Nutrition 25, 391-406.
3. Canete, R., Gil-Campos, M., Aguilera, C.M. and Gil, A. (2007) Development of insulin resistance and its relation to diet in the obese child. European Journal of Nutrition 46, 181-187.
4. Lerer, L.B., Lopez, A.D., Kjellstrom, T. and Yach, D. (1998) Health for all: analyzing health status and determinants. World Health Statistics Quarterly 51, 7-20.
5. National Institute for Health and Clinical Excellence (NICE). (2006) Obesity: The Prevention I, Assessment and Management of Overweight and Obesity in Adults and Children. Clinical guideline. CG43. National Institute for Health and Clinical Excellence (NICE). Report, London.
6. EU Members. (2005) EU platform on diet physical activity and health,15th March 2005, Diet, physical activity and health-a European platform for action. Report.
7. Tur, J.A. and Gil, A. (2010) Suplementos nutricionales. In: Tratado de Nutrición. (Gil, A., ed.), vol. 2, p. 477, Editorial Médica Panamericana, Madrid.
8. Pittler, M.H., Schmidt, K. and Ernst, E. (2005) Adverse events of herbal food supplements for body weight reduction: systematic review. Obes. Rev. 6, 93-111.
9. Dwyer, J.T., Allison, D.B. and Coates, P.M. (2005) Dietary supplements in weight reduction. Journal of the American Dietetic Association 105, S80-86.
10. Saper, R.B., Eisenberg, D.M. and Phillips, R.S. (2004) Common dietary supplements for weight loss. American Family Physician 70, 1731-1738.
11. Pittler, M.H. and Ernst, E. (2005) Complementary therapies for reducing body weight: a systematic review. International Journal of Obesity 29, 1030-1038.
12. Talpur, N.A., Echard, B.W., Manohar, V. and Preuss, H.G. (2001) Infl uence of a combination of herbs on appetite suppression and weight loss in rats. Diabetes, Obesity & Metabolism 3, 181-185.
13. Papathanasopoulos, A. and Camilleri, M. (2010) Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology 138, 65-72 e61-62.
14. Blanck, H.M., Serdula, M.K., Gillespie, C., Galuska, D.A., Sharpe, P.A., Conway, J.M., Khan, L.K. and Ainsworth, B.E. (2007) Use of nonprescription dietary supplements for weight loss is common among Americans. Journal of the American Dietetic Association 107, 441-447.
15. Cope, M.B., Erdman, J.W., Jr. and Allison, D.B. (2008) The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Obes. Rev. 9, 219-235.
16. Velasquez, M.T. and Bhathena, S.J. (2007) Role of dietary soy protein in obesity. International Journal of Medical Sciences 4, 72-82.
17. Dyck, J.R., Berthiaume, L.G., Thomas, P.D., Kantor, P.F., Barr, A.J., Barr, R., Singh, D., Hopkins, T.A., Voilley, N., Prentki, M. and Lopaschuk, G.D. (2000) Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism. The Biochemical Journal 350 Pt 2, 599-608.
18. Cederroth, C.R., Vinciguerra, M., Gjinovci, A., Kuhne, F., Klein, M., Cederroth, M., Caille, D., Suter, M., Neumann, D., James, R.W., Doerge, D.R., Wallimann, T., Meda, P., Foti, M., Rohner-Jeanrenaud, F., Vassalli, J.D. and Nef, S. (2008) Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57, 1176-1185.
19. Hwang, J.T., Park, I.J., Shin, J.I., Lee, Y.K., Lee, S.K., Baik, H.W., Ha, J. and Park, O.J. (2005) Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochemical and Biophysical Research Communications 338, 694-699.
20. Martinez-Villaluenga, C., Dia, V.P., Berhow, M., Bringe, N.A. and Gonzalez de Mejia, E. (2009) Protein hydrolysates from beta-conglycinin enriched soybean genotypes inhibit lipid accumulation and infl ammation in vitro. Molecular Nutrition & Food Research 53, 1007-1018.
21. Martinez-Villaluenga, C., Rupasinghe, S.G., Schuler, M.A. and Gonzalez de Mejia, E. (2010) Peptides from purified soybean beta-conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain. The FEBS Journal 277, 1481-1493.
22. Veldhorst, M.A., Nieuwenhuizen, A.G., Hochstenbach-Waelen, A., Westerterp, K.R., Engelen, M.P., Brummer, R.J., Deutz, N.E. and Westerterp-Plantenga, M.S. (2009) Effects of high and normal soyprotein breakfasts on satiety and subsequent energy intake, including amino acid and 'satiety' hormone responses. European Journal of Nutrition 48, 92-100.
23. Dafopoulos, K., Chalvatzas, N., Kosmas, G., Kallitsaris, A., Pournaras, S. and Messinis, I. E. (2010) The effect of estrogens on plasma ghrelin concentrations in women. Journal of Endocrinology Investigation. 33, 109-12.
24. Matvienko, O.A., Alekel, D.L., Genschel, U., Ritland, L., Van Loan, M.D. and Koehler, K.J. (2010) Appetitive hormones, but not isofl avone tablets, infl uence overall and central adiposity in healthy postmenopausal women. Menopause 17, 594-601.
25. Weickert, M.O., Reimann, M., Otto, B., Hall, W.L., Vafeiadou, K., Hallund, J., Ferrari, M., Talbot, D., Branca, F., Bugel, S., Williams, C.M., Zunft, H.J. and Koebnick, C. (2006) Soy isofl avones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. Journal of Negative Results in Biomedicine 5, 11.
26. Bermudez Menendez de la Granda, M. and Sinclair, A.J. (2009) Fatty acids and obesity. Current Pharmaceutical Design 15, 4117-4125.
27. Cicero, A.F., Ertek, S. and Borghi, C. (2009) Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Current Vascular Pharmacology 7, 330-337.
28. Calder, P.C. (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond) 107,1-11.
29. Harris, W.S. and Bulchandani, D. (2006) Why do omega-3 fatty acids lower serum triglycerides? Current Opinion in Lipidology 17, 387-393.
30. Das, U.N. (2008) Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-infl ammatory, cytoprotective, and cardioprotective molecules. Lipids in Health and Disease 7, 37.
31. Schwab, U., Callaway, J., Erkkilä, A., Gynther, J., Uusitupa, M. and Järvinen, T. (2006) Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic. European Journal of Nutrition 45, 470-7.
32. Schirmer, M.A. and Phinney, S.D. (2007) Gammalinolenate reduces weight regain in formerly obese humans. The Journal of Nutrition 137, 1430-1435.
33. Yamamoto, K., Takeshita, M., Tokimitsu, I., Watanabe, H., Mizuno, T., Asakawa, H., Tokunaga, K., Tatsumi, T., Okazaki, M. and Yagi, N. (2006) Diacylglycerol oil ingestion in type 2 diabetic patients with hypertriglyceridemia. Nutrition 22, 23-29.
34. Ai, M., Tanaka, A., Shoji, K., Ogita, K., Hase, T., Tokimitsu, I. and Shimokado, K. (2007) Suppressive effects of diacylglycerol oil on postprandial hyperlipidemia in insulin resistance and glucose intolerance. Atherosclerosis 195, 398-403.
35. Li, D., Xu, T., Takase, H., Tokimitsu, I., Zhang, P., Wang, Q., Yu, X. and Zhang, A. (2008) Diacylglycerol-induced improvement of whole-body insulin sensitivity in type 2 diabetes mellitus: a long-term randomized, double-blind controlled study. Clinical Nutrition 27, 203-211.
36. Hibi, M., Takase, H., Meguro, S. and Tokimitsu, I. (2009) The effects of diacylglycerol oil on fat oxidation and energy expenditure in humans and animals. BioFactors 35, 175-177.
37. Hibi, M., Takase, H., Yasunaga, K., Yamaguchi, T., Harada, U., Katsuragi, Y. and Tokimitsu, I. (2008) Fat utilization in healthy subjects consuming diacylglycerol oil diet: dietary and whole body fat oxidation. Lipids 43, 517-524.
38. Hibi, M., Takase, H., Yasunaga, K., Yamaguchi, T., Shiiba, D., Saito, S., Yokoyama, R., Kudo, N., Katsuragi, Y., Meguro, S., Shimizu, A. and Tokimitsu, I. (2008) Greater fat oxidation with diacylglycerol oil consumption for 14 days compared with triacylglycerol oil consumption in overweight men and women. International Journal of Obesity 32, 1841-1847.
39. Aro A (2006) The scientific basis for trans fatty acid regulations-is it sufficient? A European perspective. Atheroscler Suppl 7:67-68.
40. FAO (2010) Fats and fatty acids in human nutrition. A joint FAO/WHO report of an expert consultation. FAO Food and Nutrition Paper 3, pp. 1-166, FAO, Rome.
41. Whigham, L.D., Watras, A.C. and Schoeller, DA (2007) Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. The American Journal of Clinical Nutrition 85, 1203-1211.
42. Wang YW, Jones PJ (2004) Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 28: 941-955.
43. Kennedy, A., Martinez, K., Schmidt, S., Mandrup, S., LaPoint, K. and McIntosh, M. Antiobesity mechanisms of action of conjugated linoleic acid. The Journal of Nutritional Biochemistry 21, 171-179.
44. Alemany, M., Fernandez-Lopez, J.A., Petrobelli, A., Granada, M., Foz, M. and Remesar, X. (2003) Weight loss in a patient with morbid obesity under treatment with oleoyl-estrone. Medicina Clinica 121, 496-499.
45. Garcia-Pelaez, B., Vila, R. and Remesar, X. (2007) Oleoyl-estrone treatment to late pregnant and midlactating rats affects the expression of lipid metabolism genes. Lipids 42, 827-833.
46. Garcia-Pelaez, B., Vila, R. and Remesar, X. (2007) The administration of oleoyl-estrone to lactating dams induces selective changes in the normal growth pattern of their pups. Hormone and Metabolic Research 39, 582-588.
47. Halford, J.C. (2006) Obesity drugs in clinical development. Curr. Opin. Investig. Drugs 7, 312-318.
48. Alfenas, R.C. and Mattes, R.D. (2005) Infl uence of glycemic index/load on glycemic response, appetite, and food intake in healthy humans. Diabetes Care 28, 2123-2129.
49. Gaesser, G.A. (2007) Carbohydrate quantity and quality in relation to body mass index. Journal of the American Dietetic Association 107, 1768-1780.
50. Anderson, J.W., Baird, P., Davis, R.H., Jr., Ferreri, S., Knudtson, M., Koraym, A., Waters, V. and Williams, C.L. (2009) Health Benefits of Dietary Fiber. Nutrition Reviews 67, 188-205.
51. Marlett, J.A., McBurney, M.I. and Slavin, J.L. (2002) Position of the American Dietetic Association: health implications of dietary fiber. Journal of the American Dietetic Association 102, 993-1000.
52. Ludwig, D.S. (2002) The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287, 2414-2423.
53. Galisteo, M., Duarte, J. and Zarzuelo, A. (2008) Effects of dietary fibers on disturbances clustered in the metabolic syndrome. The Journal of Nutritional Biochemistry 19, 71-84.
54. Slavin, J.L. (2008) Position of the American Dietetic Association: health implications of dietary fiber. Journal of the American Dietetic Association 108, 1716-1731.
55. Koh-Banerjee, P., Franz, M., Sampson, L., Liu, S., Jacobs, D.R., Jr., Spiegelman, D., Willett, W. and Rimm, E. (2004) Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. The American Journal of Clinical Nutrition 80, 1237-1245.
56. Hamedani, A., Akhavan, T., Samra, R.A. and Anderson, G.H. (2009) Reduced energy intake at breakfast is not compensated for at lunch if a high-insolublefiber cereal replaces a low-fiber cereal. The American Journal of Clinical Nutrition 89, 1343-1349.
57. Pacholec, M., Bleasdale, J.E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R.S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., Qiu, X., Stockman, B., Thanabal, V., Varghese, A., Ward, J., Withka, J. and Ahn, K. (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285, 8340-8351.
58. Witkamp, R.F. (2011) Current and future drug targets in weight management. Pharm. Res. 28,1792-1818. doi 10.1007/s11095-010-0341-1.
59. Guarente, L. (2006) Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874.
60. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., McBurney, M.W. and Guarente, L. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776.
61. Rayalam, S., Della-Fera, M.A. and Baile, C.A. (2011) Synergism between resveratrol and other phytochemicals: Implications for obesity and osteoporosis. Molecular Nutrition & Food Research 55, 1177-1185.
62. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P. and Auwerx, J. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109-1122.
63. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Le Couteur, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., de Cabo, R. and Sinclair, D.A. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
64. Hsu, C.L. and Yen, G.C. (2008) Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. Molecular Nutrition & Food Research 52, 53-61.
65. Hsu, C.L., Huang, S.L. and Yen, G.C. (2006) Inhibitory effect of phenolic acids on the proliferation of 3T3-L1 preadipocytes in relation to their antioxidant activity. Journal of Agricultural and Food Chemistry 54: 4191-4197.
66. Lin, J., Della-Fera, M.A. and Baile, C.A. (2005) Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obesity Research 13, 982-990.
67. Thielecke, F. and Boschmann, M. (2009) The potential role of green tea catechins in the prevention of the metabolic syndrome-a review. Phytochemistry 70, 11-24.
68. Yonei, Y., Takahashi, Y., Hibino, S., Watanabe, M. and Yoshioka, T. (2008) Effects on the Human Body of a Dietary Supplement Containing L-Carnitine and Garcinia cambogia Extract: A Study using Doubleblind Tests. Journal of Clinical Biochemistry and Nutrition 42, 89-103.
69. Foster, D.W. (2004) The role of the carnitine system in human metabolism. Annals of the New York Academy of Sciences 1033, 1-16.
70. Sanyal, S., Kuvin, J.T. and Karas, R.H. (2010). Niacin and laropiprant. Drugs Today (Barc) 46, 371-378.